CBIO vs BNTC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

CBIO

58.4
AI Score
VS
CBIO Wins

BNTC

44.1
AI Score

Investment Advisor Scores

CBIO

58score
Recommendation
HOLD

BNTC

44score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CBIO BNTC Winner
Net Income -48.12M -32.74M BNTC
Operating Income -51.09M -36.76M BNTC
ROE -29.5% -17.9% BNTC
ROA -26.3% -17.5% BNTC
Total Assets 182.76M 187.00M BNTC
Cash 171.59M 184.76M BNTC
Current Ratio 9.66 56.82 BNTC
Free Cash Flow -28.56M -11.61M BNTC

Relative Price Performance (Last 90 Days)

CBIO 1M: -22.8% · 3M: -15.6% BNTC 1M: -30.3% · 3M: -32.0%

Current Technical Phase

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 35.6 · Price: $14.32

BNTC

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.9%), weak momentum, RSI 27

RSI (14): 27.4 · Price: $8.98

Fundamentals Snapshot

Metric CBIO BNTC
Market Cap — —
Forward P/E -5.4 -8.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 1.0% 0.0%
Operating Margin -14.3% 0.0%
EPS -0.14 -0.98
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.